Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study
- PMID: 34496775
- PMCID: PMC8427887
- DOI: 10.1186/s12885-021-08741-4
Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study
Abstract
Background: This study aimed to investigate the incidence and long-term survival outcomes of occult lung cancer between 2004 and 2015.
Methods: A total of 2958 patients were diagnosed with occult lung cancer in the 305,054 patients with lung cancer. The entire cohort was used to calculate the crude incidence rate. Eligible 52,472 patients (T1-xN0M0, including 2353 occult lung cancers) were selected from the entire cohort to perform survival analyses after translating T classification according to the 8th TNM staging system. Cancer-specific survival curves for different T classifications were presented.
Results: The crude incidence rate of occult lung cancer was 1.00 per 100 patients, and it was reduced between 2004 and 2015 [1.4 per 100 persons in 2004; 0.6 per 100 persons in 2015; adjusted risk ratio = 0.437, 95% confidence interval (CI) 0.363-0.527]. In the survival analysis, there were 2206 death events in the 2353 occult lung cancers. The results of the multivariable analysis revealed that the prognoses with occult lung cancer were similar to patients with stage T3N0M0 (adjusted hazard ratio = 1.054, 95% CI 0.986-1.127, p = 0.121). Adjusted survival curves presented the same results. In addition, adjusted for other confounders, female, age ≤ 72 years, surgical treatment, radiotherapy, adenocarcinoma, and non-squamous and non-adenocarcinoma non-small cell carcinoma were independent protective prognostic factors (all p < 0.05).
Conclusions: Occult lung cancer was uncommon. However, the cancer-specific survival of occult lung cancer was poor, therefore, we should put the assessment of its prognoses on the agenda. Timely surgical treatment and radiotherapy could improve survival outcomes for those patients. Besides, we still need more research to confirm those findings.
Keywords: And end results database; Epidemiology; Incidence; Occult lung cancer; Surveillance; Survival.
© 2021. The Author(s).
Conflict of interest statement
There are no conflicts of interest to declare.
Figures
Similar articles
-
Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.BMC Cancer. 2020 Nov 10;20(1):1081. doi: 10.1186/s12885-020-07603-9. BMC Cancer. 2020. PMID: 33172389 Free PMC article.
-
Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population-based retrospective study using SEER data.Thorac Cancer. 2020 Jun;11(6):1522-1532. doi: 10.1111/1759-7714.13420. Epub 2020 Apr 16. Thorac Cancer. 2020. PMID: 32301286 Free PMC article.
-
A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.Ann Surg Oncol. 2019 Jul;26(7):2053-2062. doi: 10.1245/s10434-019-07318-7. Epub 2019 Mar 21. Ann Surg Oncol. 2019. PMID: 30900105
-
Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Arch Phys Med Rehabil. 2008. PMID: 18373987 Review.
-
[Gender-associated differences of lung cancer and mechanism].Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):625-30. doi: 10.3779/j.issn.1009-3419.2011.07.12. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21762635 Free PMC article. Review. Chinese.
Cited by
-
Development and validation of a novel nomogram to predict the overall survival of patients with large cell lung cancer: A surveillance, epidemiology, and end results population-based study.Heliyon. 2023 May 6;9(5):e15924. doi: 10.1016/j.heliyon.2023.e15924. eCollection 2023 May. Heliyon. 2023. PMID: 37223713 Free PMC article.
-
Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China.Transl Lung Cancer Res. 2022 Aug;11(8):1591-1605. doi: 10.21037/tlcr-22-240. Transl Lung Cancer Res. 2022. PMID: 36090636 Free PMC article.
-
The postoperative prognosis of skip-N2 metastasis is favorable in small-cell lung carcinoma patients with pathological N2 classification: a propensity-score-adjusted retrospective multicenter study.Ther Adv Med Oncol. 2023 Jan 10;15:17588359221146134. doi: 10.1177/17588359221146134. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36643656 Free PMC article.
-
The Effect of Examined Lymph Nodes and Lymph Node Ratio on Pathological Nodal Classification in the Lung Adenosquamous Carcinoma After Lobectomy.Front Surg. 2022 Jun 9;9:909810. doi: 10.3389/fsurg.2022.909810. eCollection 2022. Front Surg. 2022. PMID: 35756483 Free PMC article.
-
The Construction and Validation of Nomogram to Predict the Prognosis with Small-Cell Lung Cancer Followed Surgery.Cancers (Basel). 2022 Jul 30;14(15):3723. doi: 10.3390/cancers14153723. Cancers (Basel). 2022. PMID: 35954386 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical